2,6-Dichloro-4-morpholin-4-YL-benzaldehyde → 6-[5-(4-Chloro-phenyl)-[1,3,4]oxadiazol-2-yl]-2-(2,6-dichloro-4-morpholin-4-yl-phenyl)-1H-benzoimidazole
반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:12][C:11]([C:13]3[CH:14]=[C:15]([NH2:20])[C:16]([NH2:19])=[CH:17][CH:18]=3)=[N:10][N:9]=2)=[CH:4][CH:3]=1.[Cl:21][C:22]1[CH:29]=[C:28]([N:30]2[CH2:35][CH2:34][O:33][CH2:32][CH2:31]2)[CH:27]=[C:26]([Cl:36])[C:23]=1[CH:24]=O>CS(C)=O>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[O:12][C:11]([C:13]3[CH:18]=[CH:17][C:16]4[N:19]=[C:24]([C:23]5[C:22]([Cl:21])=[CH:29][C:28]([N:30]6[CH2:31][CH2:32][O:33][CH2:34][CH2:35]6)=[CH:27][C:26]=5[Cl:36])[NH:20][C:15]=4[CH:14]=3)=[N:10][N:9]=2)=[CH:6][CH:7]=1참가 물질
실험 절차
To a 50 ml rbf was added 0.2250 g (0.785 mmol) 4-[5-(4-Chloro-phenyl)-[1,3,4]oxadiazol-2-yl]benzene-1,2-diamine, 0.2041 g (0.785 mmol) of 2,6-Dichloro-4-morpholin-4-yl-benzaldehyde, and 5 mL of DMSO. To this dark brown solution was added 0.0190 g (0.118 mmol) of FeCl3. It was allowed to stir open to air for 18 h. The crude was then extracted with EtOAc, and the combined extracts were washed with water, brine and dried with Na2SO4. The volatiles were removed in vacuo and the concentrate was purified on silica gel (ACN/DCM, 1:9 to 10:0) to give the title compound. 1H NMR (400 MHz, DMSO-d6) δ ppm 3.30 (d, J=5.05 Hz, 4 H) 3.71-3.77 (m, 4 H) 7.17 (s, 2 H) 7.70-7.75 (m, 2 H) 7.90 (d, J=8.72 Hz, 1 H) 7.99-8.07 (m, 1 H) 8.19 (d, J=8.21 Hz, 2 H) 8.27 (br. s., 1 H) 8.47 (s, 1 H) 13.17 (d, J=8.97 Hz, 1H. MS (m/z) 528.0 M (+1), tR=1.41, Meth 10
후처리
- extractionThe crude was then extracted with EtOAc
- washthe combined extracts were washed with water, brine
- dry with materialdried with Na2SO4
- customThe volatiles were removed in vacuo
- customthe concentrate was purified on silica gel (ACN/DCM, 1:9 to 10:0)
출처 및 근거
- ORD 기록
- ord-52fab5bf56004a1586513fc5b54d2140
- 출처 데이터셋
- uspto-grants-2012_07
- 특허 번호
- US08217065B2
반응 노트
불러오는 중…